Skip to main content
Equibles

CSS LLC/IL

Position in HIMS — Hims & Hers Health, Inc.

CIK 1103646 CHICAGO, IL
Back to HIMS Full portfolio

Position in HIMS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,086,488
+$305,580 QoQ
Shares Held
31,338
-16.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#211
of 507 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Derivatives in HIMS

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$3,030,158
PutShares
87,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CSS LLC/IL holds $5,738,432 across 10 Drug Manufacturers - Specialty & Generic names. HIMS ranks #1 (18.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
This page 		31,338 $1,086,488
2 NBIX
Neurocrine Biosciences Inc
 6,350 $1,070,229
3 ZTS
Zoetis Inc.
 14,510 $1,042,688
4 UTHR
UNITED THERAPEUTICS Corp
 1,892 $1,025,142
5 TEVA
Teva Pharmaceutical Industries Ltd
 27,070 $917,131
6 TRLV
Trulieve Cannabis Corp.
 29,875 $293,671
7 VTRS
Viatris Inc
 11,120 $176,585
8 YCBD
cbdMD, Inc.
 137,621 $92,618

All Filings in HIMS

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,086,488 31,338
2026-06-30 $3,030,158 87,400
2026-03-31 $1,814,424 87,400
2026-03-31 $780,908 37,616
2025-12-31 $3,243,753 99,900
2025-09-30 $3,630,080 64,000
2025-06-30 $997,000 20,000
2021-03-31 $377,293 28,518
2021-03-31 $398,223 30,100